ABG INNOVATION CAPITAL PARTNERS III GP LTD Holdings

ABG INNOVATION CAPITAL PARTNERS III GP LTD is an investment fund managing more than 1.48M US dollars. The largest holdings include Castle Biosciences, Aadi Bioscience and Synlogic. In Q2 2022 the fund bought assets of total value of 738K US dollars and sold assets of total value of 11K US dollars.

$1.47M

portfolio value

+10.68%

quarter

-63.68%

1 year

ABG INNOVATION CAPITAL PARTNERS III GP LTD portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2021	162969000	110265000
Q2 2021	27186000	200887000
Q3 2021	783000	27186000
Q2 2022	738000	11000

ABG INNOVATION CAPITAL PARTNERS III GP LTD 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Diagnostics & Research Castle Biosciences, Inc. Portfolio share: 59.46% Portfolio value: 877K Avg. open price: N/A Current price: $24.41 P/L: N/A N/A Q2 2022	share	59.46%	877K	N/A	$24.41	N/A	N/A Q2 2022
Biotechnology Aadi Bioscience, Inc. Portfolio share: 25.56% Portfolio value: 377K Avg. open price: N/A Current price: $13.42 P/L: N/A N/A Q3 2021	share	25.56%	377K	N/A	$13.42	N/A	N/A Q3 2021
Biotechnology Synlogic, Inc. Portfolio share: 13.29% Portfolio value: 196K Avg. open price: N/A Current price: $0.74 P/L: N/A N/A Q4 2020	share	13.29%	196K	N/A	$0.74	N/A	N/A Q4 2020
Biotechnology Idera Pharmaceuticals, Inc. Portfolio share: 1.42% Portfolio value: 21K Avg. open price: N/A Current price: $0.32 P/L: N/A N/A Q4 2020	share	1.42%	21K	N/A	$0.32	N/A	N/A Q4 2020
Biotechnology Genocea Biosciences, Inc. Portfolio share: 0.27% Portfolio value: 4K Avg. open price: N/A Current price: $0.01 P/L: N/A N/A Q4 2020	share	0.27%	4K	N/A	$0.01	N/A	N/A Q4 2020
Biotechnology Nabriva Therapeutics plc Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.14 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$2.14	N/A	Sold -100.00% shares Q3 2022

Showing TOP 6 ABG INNOVATION CAPITAL PARTNERS III GP LTD's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of ABG INNOVATION CAPITAL PARTNERS III GP LTD?

The biggest position of the ABG INNOVATION CAPITAL PARTNERS III GP LTD is Castle Biosciences, Inc. (CSTL) with 59.46% portfolio share worth of 877K US dollars.

Top 5 ABG INNOVATION CAPITAL PARTNERS III GP LTD's holdings represent 100% of the portfolio:

Castle Biosciences, Inc. (CSTL) – 59.46%
Aadi Bioscience, Inc. (AADI) – 25.56%
Synlogic, Inc. (SYBX) – 13.29%
Idera Pharmaceuticals, Inc. (IDRA) – 1.42%
Genocea Biosciences, Inc. (GNCA) – 0.27%

Who is the portfolio manager of ABG INNOVATION CAPITAL PARTNERS III GP LTD?

The portfolio manager of the ABG INNOVATION CAPITAL PARTNERS III GP LTD is .

What is the total asset value of the ABG INNOVATION CAPITAL PARTNERS III GP LTD portfolio?

ABG INNOVATION CAPITAL PARTNERS III GP LTD total asset value (portfolio value) is 1.48M US dollars.

Who is ?

is the portfolio manager of the ABG INNOVATION CAPITAL PARTNERS III GP LTD.

What is (ABG INNOVATION CAPITAL PARTNERS III GP LTD) fund performance?

ABG INNOVATION CAPITAL PARTNERS III GP LTD's quarterly performance is +10.68%, annualy -63.68%.

What is the ABG INNOVATION CAPITAL PARTNERS III GP LTD CIK?

ABG INNOVATION CAPITAL PARTNERS III GP LTD's Central Index Key is 0001845297 .